Skip to content
Recall Observatory FDA recall evidence

Drug product

Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S Indoco Remedies Limited., L-32, 33, 34, Verna Industrial area, Verna - Goa, 403722, India; Mfd. for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-341-35.

D-1283-2022

July 14, 2022

Class II

Product summary

Firm
CIPLA
Event
Event 90608
Status
Terminated
Classification
Class II
Quantity
8,136 bottles
Official record key
drug-enforcement:D-1283-2022

Official wording

Reason: Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

Code information: Batch# DEG4LC2, exp. date 05/2023

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility